ClinicalTrials.Veeva

Menu

A Comparison of High-flow Nasal Oxygen and Conventional Nasal Cannula in Monitored Anesthesia Care for Endoscopic Submucosal Dissection

Yonsei University logo

Yonsei University

Status

Not yet enrolling

Conditions

Patients Undergoing Endoscopic Submucosal Dissection

Treatments

Device: high-flow humidified oxygen-delivery system (OptiFlow THRIVE)
Device: conventional oxygenation (nasal cannula)

Study type

Interventional

Funder types

Other

Identifiers

NCT06688019
4-2024-1108

Details and patient eligibility

About

Sedation for endoscopic submucosal dissection places patients at risk of desaturation, and high-flow nasal oxygen may reduce the risk. The aim of this study is to evaluate the role of high-flow nasal oxygen during endoscopic submucosal dissection. We will compare the incidence of hypoxemia (defined as SpO2 lower than 90%) of conventional nasal oxygen cannula group and that of high-flow humidified oxygen-delivery system group during the procedure.

Enrollment

200 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who will undergo endoscopic sumucosal dissection under remimazolam-based sedation

Exclusion criteria

  • dementia or cognitive dysfunction
  • altered mental status
  • intubated patients or tracheostomy
  • pregnancy
  • recent history of nasal bleeding
  • contraindication for positive pressure ventilation
  • patients under oxygen therapy
  • illiteracy or foreigner

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

conventional oxygenation (nasal cannula) arm
Experimental group
Description:
conventional oxygenation arm will receive oxygen at 2L/min via nasal cannula
Treatment:
Device: conventional oxygenation (nasal cannula)
high-flow humidified oxygen-delivery system (OptiFlow THRIVE) arm
Experimental group
Description:
Optiflow THRIVE arm will receive oxygen at 50 L/min via Optiflow THRIVE
Treatment:
Device: high-flow humidified oxygen-delivery system (OptiFlow THRIVE)

Trial contacts and locations

0

Loading...

Central trial contact

Namo Kim

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems